Related Experiment Videos

Caudal epidural morphine analgesia for an infant with advanced neuroblastoma: report of a case

Charles B Berde1, Nathan Fischel, Pierre J Filardi

  • 1Dept. of Anesthesia, Children's Hospital, Boston, MA 02115 U.S.A. Div. of Pediatric Oncology, Children's Hospital, Boston, MA 02115 U.S.A. Dept. of Nursing, Children's Hospital, Boston, MA 02115 U.S.A.

Pain
|February 1, 1989
PubMed

Insights

Caudal epidural morphine provided effective, prolonged pain relief for an infant with neuroblastoma. This technique is a feasible option for managing cancer pain in patients of all ages.

Area of Science:

  • Pediatric Anesthesiology
  • Oncology Pain Management
  • Palliative Care

Background:

  • Neuroblastoma is a common pediatric cancer often associated with significant pain.
  • Effective pain management in infants presents unique challenges due to physiological differences.
  • Caudal epidural analgesia is an established regional anesthesia technique.

Observation:

  • A 5-month-old infant with neuroblastoma and abdominal distension experienced severe pain.
  • Intermittent caudal epidural injections of morphine were administered.
  • Treatment was performed on 6 occasions over a 1-week period.

Findings:

  • Each caudal epidural morphine injection resulted in prolonged analgesia, lasting 17-20 hours.
  • Improved depth of respiration was observed after each administration.
  • The infant experienced significant pain relief and improved respiratory function.

Implications:

  • Caudal epidural opioid administration is technically feasible for pediatric cancer pain.
  • This method offers a viable alternative for managing severe pain in infants and children with cancer.
  • Epidural opioid analgesia can be considered a safe and effective option across all age groups for cancer pain relief.

Related Concept Videos